Abiopharma

Change - Announcement of Cessation: Resignation of Chief Financial Officer

New Form SCHEDULE 13G/A - Merlin, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001493152-26-037660 <b>Size:</b> 12 KB

New Form SCHEDULE 13G/A - Forte Biosciences, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000209 <b>Size:</b> 13 KB

New Form SCHEDULE 13G/A - Mirum Pharmaceuticals, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000210 <b>Size:</b> 13 KB

Change - Announcement of Appointment: Re-designation of Mr. Lee Kiang Leng Stanley as Executive Chairman and Chief Executive Officer

New Form SCHEDULE 13G/A - ASSEMBLY BIOSCIENCES, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000208 <b>Size:</b> 13 KB

Started to be an interested party - Meitav Investment House Ltd.

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G/A - Dyne Therapeutics, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000206 <b>Size:</b> 12 KB

New Form SCHEDULE 13G/A - Tarsus Pharmaceuticals, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000207 <b>Size:</b> 12 KB

New Form SCHEDULE 13G - FingerMotion, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001493152-26-037658 <b>Size:</b> 11 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023679 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - ICU MEDICAL INC/DE <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000203 <b>Size:</b> 12 KB

New Form SCHEDULE 13G - Flutter Entertainment plc <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001045520-26-000010 <b>Size:</b> 6 KB

New Form SCHEDULE 13G/A - ZIFF DAVIS, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000204 <b>Size:</b> 13 KB